Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs Vir Biotechnology, Inc. (VIR)

Biohaven Ltd. and Vir Biotechnology, Inc. are both Biotechnology companies. Biohaven Ltd. and Vir Biotechnology, Inc. are of similar size ($2.3B and $2.3B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,696.0% against 425.2%. Biohaven Ltd. has the higher net margin (0.00% vs −61.0%) and the lower return on invested capital (−6,659.9% vs −30.3%). Across the 16 metrics below, Biohaven Ltd. leads on 9 and Vir Biotechnology, Inc. on 7.

Valuation

Metric BHVN VIR Biotechnology median
P/E n/m n/m 11.58
P/S 2.30 7.33 9.61
P/B n/m 2.48 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 2.40 5.81 9.43
Earnings yield (25.43%) (9.52%) (32.28%)
Free cash flow yield (21.52%) (6.39%) (22.27%)

Profitability

Metric BHVN VIR Biotechnology median
Gross margin 0.00% 99.99% 68.81%
Operating margin 0.00% (69.82%) 0.00%
Net margin 0.00% (61.03%) 0.00%
Free cash flow margin 0.00% (46.87%) 0.00%
Return on equity 940.46% (21.84%) (50.30%)
Return on assets (161.32%) (17.34%) (45.47%)
Return on invested capital (6,659.91%) (30.32%) 0.00%

Growth

Metric BHVN VIR Biotechnology median
Revenue growth (TTM) 425.20% 1,695.96% 6.78%
EPS growth (last fiscal year) 26.08% 17.49% 29.88%
Revenue growth, 5-year CAGR — (2.14%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BHVN VIR Biotechnology median
Debt to equity (2.69) 0.00 0.00
Current ratio 3.05 6.30 4.74
Net debt to EBITDA 0.11 1.02 1.01

Dividend

Metric BHVN VIR Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric BHVN VIR Biotechnology median
Market cap 2.28b 2.25b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack